Showing results (11-20 of 720) with videos related to

Sort By:
Pageof 72
The Lancet. Haematology|March 31, 2022
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort studyCarla Casulo, Melissa C Larson, Julianne J Lunde, et al.
The Lancet. Haematology|March 31, 2022
Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendationsMonia Marchetti, Alessandro Maria Vannucchi, Martin Griesshammer, et al.
The Lancet. Haematology|February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
The Lancet. Haematology|February 3, 2022
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working GroupNoopur S Raje, Elias Anaissie, Shaji K Kumar, et al.
The Lancet. Haematology|February 3, 2022
Risk stratified management approaches for smouldering multiple myeloma: clinical research becomes clinical practiceSagar Lonial, S Vincent Rajkumar, Maria Victoria Mateos
The Lancet. Haematology|February 1, 2022
Malignancy-associated haemophagocytic lymphohistiocytosisAudi Setiadi, Adi Zoref-Lorenz, Christina Y Lee, et al.
The Lancet. Haematology|March 3, 2022
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control studyBrigitte Ranque, Robert Kitenge, Dado Doucoure Ndiaye, et al.
The Lancet. Haematology|December 18, 2022
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trialKwee Yong, William Wilson, Ruth M de Tute, et al.
The Lancet. Haematology|January 2, 2026
Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resourcesKhaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, et al.
The Lancet. Haematology|September 5, 2021
Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving careClement D Okello, Nixon Niyonzima, Marta Ferraresso, et al.
Pageof 72